ResMed Inc. on November 9, 2023, announced that Robert Douglas, chief operating officer and president, will transition to a role as special advisor to the CEO effective immediately and will retire, effective January 1, 2024. Mr. Douglas has served as an executive officer of ResMed for over twelve years. Until his retirement, Mr. Douglas will continue to receive his current salary, benefits, and vesting of long-term equity incentives. In connection with his
retirement, have agreed that Mr. Douglas will remain eligible for a pro-rata portion of his short-term incentive cash payment for fiscal year 2024, on the same basis as similarly situated executives, based on his continued employment through December 31, 2023, even though he will not be employed on the date of the payment. From January 2, 2024, through December 31, 2024, Mr. Douglas will serve as a consultant to us, to assist with the transition of his former duties. have agreed to compensate him for these consulting services at a rate of $10,000 per month. In addition, he will remain eligible for continued vesting of outstanding equity awards, during the consulting period, in accordance with the terms of equity incentive plans, and the specific equity grants previously made to him. ResMed's new Product-led, Customer-centric, and Brand-enhanced operating model includes the following executive leadership team: Leaders appointed into new roles: Chief Product Officer ­ Justin Leong (previously president, Asia and Latin America), Chief Marketing Officer ­ Katrin Pucknat (previously president, Germany), Chief Revenue Officer ­ Mike Fliss (previously vice president, North America sales). In addition to the above roles, the executive leadership team also includes: Chief Commercial Officer, SaaS ­ Bobby Ghoshal, Chief Financial Officer ­ Brett Sandercock, Chief Legal Officer ­ Mike Rider, Chief People Officer ­ Vered Keisar. Chief Strategy Officer ­ Hemanth Reddy. The extended CEO operations team, reporting directly to the CEO, includes: Chief Compliance Officer ­ Jim Ellis Chief Information Security Officer ­ Todd Friedman, Chief Investor Relations Officer ­ Amy Wakeham, Chief Medical Officer ­ Carlos Nunez, Chief Quality & Regulatory Officer ­ Dawn Haake, Chief Supply Chain Officer ­ Andrew Price.